Elevated NEFA was acknowledged to be involved in diabetes by impairing insulin action, and despite higher NEFA concentrations in obese and diabetic individuals, there was reportedly no direct clinical evidence for beta cell lipotoxicity [46]. The gene discussed is INS; the disease is diabetes mellitus.